Study Stopped
Unable to recruit sufficient number of subjects
Caries Transmission Prevention in Alaska Native Infants
Northwest Alaska Center to Reduce Oral Health Disparity Project 2: Caries Transmission Prevention in Alaska Native Infants
2 other identifiers
interventional
250
1 country
1
Brief Summary
The purpose of this study is to conduct a community based, randomized control trial to determine if the use of chlorhexidine mouth rinse and xylitol-sweetened chewing gum will reduce the vertical transmission of caries between Alaska Native mothers to their infants.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Apr 2003
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2003
CompletedFirst Submitted
Initial submission to the registry
August 15, 2003
CompletedFirst Posted
Study publicly available on registry
August 20, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2006
CompletedJune 2, 2015
April 1, 2010
3.3 years
August 15, 2003
May 29, 2015
Conditions
Study Arms (2)
Intervention group
EXPERIMENTALSubjects received chlorhexidine mouthwash and xylitol gum , in addition to the usual care specified under the control group
Control
PLACEBO COMPARATORSubjects received enhanced dental care, health information, toothbrushes and toothpaste. They also received placebo gum and placebo mouth rinse
Interventions
women received daily chlorhexidine oral rinses for two weeks prior to delivery of the infant.
Women were asked to chew xylitol chewing gum three times per day following the birth of their infant for up to two years postpartum
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
University of Washington
Seattle, Washington, 98195, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Grossman, MD MPH
University of Washington
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 15, 2003
First Posted
August 20, 2003
Study Start
April 1, 2003
Primary Completion
July 1, 2006
Study Completion
July 1, 2006
Last Updated
June 2, 2015
Record last verified: 2010-04